As of 2025-09-17, the Intrinsic Value of Atossa Therapeutics Inc (ATOS) is -1.11 USD. This Atossa valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.82 USD, the upside of Atossa Therapeutics Inc is -235.24%.
Based on its market price of 0.82 USD and our intrinsic valuation, Atossa Therapeutics Inc (ATOS) is overvalued by 235.24%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -1.11 - -1.11 | -1.11 | -235.24% |
| P/E | (0.73) - (2.45) | (1.59) | -293.4% |
| DDM - Stable | (1.51) - (8.67) | (5.09) | -719.2% |
| DDM - Multi | (1.18) - (5.66) | (1.99) | -342.6% |
| Market Cap (mil) | 106.18 |
| Beta | 2.31 |
| Outstanding shares (mil) | 129.17 |
| Enterprise Value (mil) | 48.32 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.31% |
| Cost of Debt | 5.00% |
| WACC | 6.99% |